Short answer
ICU MEDICAL INC/DE (ICUI) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results announced by ICU Medical on August 6, 2026.
ICU MEDICAL INC/DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results announced by ICU Medical on August 6, 2026
- Detailed operating results and financial metrics contained in furnished Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $551.7M, up 1% YoY; organic revenue increased 6% excluding IV Solutions divestiture and foreign currency
- Infusion Systems revenue $189.0M, up 13%; Consumables revenue $289.3M, up 6%
- GAAP gross margin expanded to 43% from 38%; adjusted EBITDA rose to $110.0M from $100.3M
- GAAP net income fell to $19.1M from $35.3M, while adjusted diluted EPS increased to $2.37 from $2.10
- FY2026 guidance raised: GAAP EPS $2.89-$3.29, adjusted EPS $8.60-$9.00, adjusted EBITDA $415M-$435M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ICU MEDICAL INC/DE 8-K filings
Get the next ICUI 8-K as it lands
Follow ICUI for push alerts, or ask the research agent what this filing means.